Study: Racial and ethnic disparities in vaccine uptake, hesitancy
Editor's Note This study by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that racial and ethnic minorities have been more hesitant or unwilling to be vaccinated for COVID-19, compared to Whites. Of study participants in the US (87,388) and UK (1,254,294): Vaccine hesitancy was greater…
FDA: Update on Class I recall of certain Philips Respironics ventilators, repair kits
Editor's Note The Food and Drug Administration (FDA) on January 26 updated the Class I recall of certain Trilogy Evo ventilators and repair kits for Trilogy Evo muffler assembly, which are manufactured by Philips Respironics. According to the update, the FDA has asked the company to have an independent laboratory…
FDA: Class I recall of Medtronic’s HawkOne Directional Atherectomy System
Editor's Note The Food and Drug Administration (FDA) on January 21 identified the recall by Medtronic Inc of its HawkOne Directional Atherectomy System as Class I, the most serious. The recall was initiated because of the risk of the guidewire within the catheter moving down ward or prolapsing when force…
FDA: Class I recall of Getinge Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems
Editor's Note The Food and Drug Administration (FDA) on January 19 identified the recall by Getinge of its Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems as Class I, the most serious. The recall was initiated because of the potential chemical breakdown of Sevoflurane that may result in inhalation…
FDA: Class I recall of Medtronic Synergy Cranial, StealthStation S7 cranial software
Editor's Note The Food and Drug Administration (FDA) on January 6 identified the recall by Medtronic of its Stealth Station System with Synergy Cranial and StealthStation S7 Cranial Software as Class I, the most serious. The System aids in precisely locating anatomical structures in neurosurgical procedures. The recall was initiated…
FDA: Class I recall of Cardiovascular Systems’ WIRION Embolic Protection Device
Editor's Note The Food and Drug Administration (FDA), on January 10, identified the recall of Cardiovascular Systems’ WIRION Embolic Protection Device as Class I, the most serious. The device, which is used to hold or remove debris or blood clots from the lower limbs, was recalled because of complaints of…
FDA: Class I recall of Puritan Bennett 980 Series Ventilator
Editor's Note The Food and Drug Administration (FDA), on January 3, identified the recall by Covidien of its Puritan Bennett 980 Series Ventilator as Class I, the most serious. The recall was initiated because of a capacitor manufacturing assembly error that may cause the ventilator to become inoperable or stop…
Meta-analysis finds high global percentage of asymptomatic COVID-19 infections
Editor's Note This study by Chinese researchers finds a high percentage of asymptomatic COVID-19 infections worldwide, which highlights the potential transmission risk of asymptomatic infections in communities. In this review and meta-analysis of 95 studies, which include nearly 30 million individuals undergoing testing, the percentage of asymptomatic infections was 0.25%…
FDA: Class I recall of Getinge/Datascope/Maquet Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps
Editor's Note The Food and Drug Administration, on December 16, identified the recall by Getinge/Datascope/Maquet of its Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The IABPs are cardiac assist devices used in patients having cardiac and noncardiac surgery and to treat patients…
Effectiveness of mRNA vaccines against COVID-19
Editor's Note This case-controlled study by researchers from White River Junction Veterans Affairs Medical Center, White River Junction, Vermont, and Dartmouth School of Medicine, Hanover, New Hampshire, finds that mRNA vaccine effectiveness against COVID-19 decreases significantly after about 6 months. In this analysis of 14,238 male veterans aged 65 or…
Free Daily News
- Market volatility threatens hospitals’ liquidity as tariff-driven costs rise
- Study: CT scan radiation could drive 5% of future cancer cases
- New studies, surgical feats advance organ transplant medicine
- Commentary: Cyberattacks threaten financial survival of surgical practices
- Tariffs strain supply chains, split medical manufacturing community
- Study: Systemic gender bias embedded in surgical practice
- Literature review: Endoscope disinfection failures highlight need for stronger sterilization practices
- Study: GLP-1 drugs heighten risk of gastric residue but not perioperative pulmonary aspiration
- OAS CAHPS compliance soars to 96% among ASCs, vendor satisfaction also improves
- Knee surgical robot market set to surge, projected to reach $5.9B by 2032